{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:10:41Z","timestamp":1790745041580,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To assess the efficacy and safety of corticosteroids for the management of pediatric sepsis and septic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Sources:<\/jats:title>\n            <jats:p>Ovid MEDLINE, Ovid Embase, CENTRAL, Web of Science (Core Collection) and China National Knowledge Infrastructure were systematically searched up to September 2023. Preprint servers, clinical trial registries and the reference sections of previous reviews were hand-searched.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study Selection:<\/jats:title>\n            <jats:p>Randomized controlled trials that enrolled pediatric sepsis, septic shock or systemic inflammatory response syndrome patients, compared the use of corticosteroid regimens against standard sepsis care and reported eligible outcomes were included. Title\/abstract and full-text screening were conducted in-duplicate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Extraction:<\/jats:title>\n            <jats:p>Eligible articles were extracted using a standardized form in-duplicate. Outcomes extracted include mortality incidence, hospital and pediatric intensive care unit length of stay, duration of shock, incidence of adverse events and serious adverse events and incidence of corticosteroid-related adverse events. The risk of bias was assessed using the Revised Cochrane Risk of Bias Tool for Assessing Randomized Trials.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Data Synthesis:<\/jats:title>\n            <jats:p>Random-effects meta-analyses were conducted, and the quality of evidence was assessed using the Grading of Recommendations, Assessment, Development and Evaluations approach. Sixteen randomized controlled trials (N = 973) were included. Corticosteroid use may be associated with reduced mortality risks (risk ratio: 0.65, 95% CI: 0.50\u20130.85), shorter length of hospital stay (MD: \u22123.76 days, 95% CI: \u22126.66 to \u22120.86), and shorter pediatric intensive care unit length of stay (MD \u22122.34 days, 95% CI: \u22123.14 to \u22121.53 days). Corticosteroid use may be associated with gastrointestinal bleeding but not a higher risk of secondary infection. No studies reported on serious adverse events. All findings were based on low to very low quality of evidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>While corticosteroids show promise for managing pediatric sepsis and septic shock, the question of how to select the best candidate and the most optimal regimen remains unanswered. Future trials need to focus on assessing corticosteroid-related adverse events and stratifying patient inclusion by sepsis subphenotypes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004551","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T19:04:37Z","timestamp":1727723077000},"page":"74-82","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Corticosteroids for Managing Pediatric Sepsis and Septic Shock: A Systematic Review and Meta-analysis"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8274-6468","authenticated-orcid":false,"given":"Jiawen","family":"Deng","sequence":"first","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON"},{"name":"Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nefissa","family":"Bedri","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, University of Ottawa, Ottawa, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8491-4090","authenticated-orcid":false,"given":"Qi Kang","family":"Zuo","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Azab","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON"},{"name":"Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7363-546X","authenticated-orcid":false,"given":"Oswin","family":"Chang","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Virdi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of British Columbia, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Hung","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Queen\u2019s University, Kingston, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaden","family":"Venugopal","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, University of Ottawa, Ottawa, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umair","family":"Tahir","sequence":"additional","affiliation":[{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4465-2249","authenticated-orcid":false,"given":"Kiyan","family":"Heybati","sequence":"additional","affiliation":[{"name":"Mayo Clinic Alix School of Medicine (Jacksonville), Mayo Clinic, Jacksonville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"R1-20250131","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20250131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock.","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"R3-20250131","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"R4-20250131","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamapediatrics.2018.4839","article-title":"Global case-fatality rates in pediatric severe sepsis and septic shock: a systematic review and meta-analysis.","volume":"173","author":"Tan","year":"2019","journal-title":"JAMA Pediatr"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock.","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"R6-20250131","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock.","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/PCC.0b013e31828a8125","article-title":"A systematic review and meta-analysis on the effect of steroids in pediatric shock.","volume":"14","author":"Menon","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R8-20250131","doi-asserted-by":"crossref","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"R10-20250131","first-page":"CD002243","article-title":"Corticosteroids for treating sepsis in children and adults.","volume":"12","author":"Annane","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R11-20250131","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/09622802231172043","article-title":"Detecting the skewness of data from the five-number summary and its application in meta-analysis.","volume":"32","author":"Shi","year":"2023","journal-title":"Stat Methods Med Res"},{"key":"R12-20250131","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jrsm.1429","article-title":"Optimally estimating the sample standard deviation from the five-number summary.","volume":"11","author":"Shi","year":"2020","journal-title":"Res Synth Methods"},{"key":"R13-20250131","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range.","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"R14-20250131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range.","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R15-20250131","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R16-20250131","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.","volume":"23","author":"Sweeting","year":"2004","journal-title":"Stat Med"},{"key":"R17-20250131","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints.","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"key":"R18-20250131","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R19-20250131","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"R20-20250131","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R21-20250131","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"R22-20250131","first-page":"485","article-title":"Pulse therapy in severe form of dengue shock syndrome.","volume":"64","author":"Futrakul","year":"1981","journal-title":"J Med Assoc Thai"},{"key":"R23-20250131","first-page":"573","article-title":"Hydrocortisone in the management of dengue shock syndrome.","volume":"6","author":"Min","year":"1975","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R24-20250131","first-page":"6","article-title":"Studies on dengue hemorrhagic fever. Clinical study: an evaluation of steroids as a treatment.","volume":"56","author":"Pongpanich","year":"1973","journal-title":"J Med Assoc Thai"},{"key":"R25-20250131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.69.1.45","article-title":"Failure of hydrocortisone to affect outcome in dengue shock syndrome.","volume":"69","author":"Sumarmo","year":"1982","journal-title":"Pediatrics"},{"key":"R26-20250131","first-page":"111","article-title":"Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study.","volume":"92","author":"Tassniyom","year":"1993","journal-title":"Pediatrics"},{"key":"R27-20250131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ppul.22574","article-title":"Efficacy of methylprednisolone in children with severe community acquired pneumonia.","volume":"48","author":"Nagy","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"R28-20250131","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00006454-199607000-00004","article-title":"Randomized, placebo-controlled, double blinded trial of dexamethasone in African children with sepsis.","volume":"15","author":"Slusher","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"R29-20250131","first-page":"734","article-title":"[The clinical effects comparison of different doses of methylprednisolone in the treatment of children with severe sepsis].","volume":"9","author":"Zeng","year":"2014","journal-title":"J Chengdu Med Coll"},{"key":"R30-20250131","first-page":"118","article-title":"[Influences of Dexamethasone combined with cefoperazone and sulbactam on efficacy of sepsis in children and serum PCT, Presepsin and NT-proBNP].","volume":"45","author":"Wang","year":"2022","journal-title":"Drug Eval Res"},{"key":"R31-20250131","first-page":"1770","article-title":"[Therapeutic effects of early application of low-dose glucocorticoid on septic shock in children and its effects on immune function of patients].","volume":"41","author":"Shi","year":"2019","journal-title":"Hebei Med J"},{"key":"R32-20250131","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/PCC.0000000000001121","article-title":"A randomized controlled trial of corticosteroids in pediatric septic shock: a pilot feasibility study.","volume":"18","author":"Menon","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R33-20250131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pcc.0000449347.12742.89","article-title":"Abstract 621: evaluation of corticosteroid replacement therapy in children with severe septic shock \u2013 a randomised intervention trial.","volume":"15","author":"de Graaf","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R34-20250131","first-page":"404","article-title":"[Observation on the treatment of septic shock in children with high-dose methylprednisolone].","volume":"18","author":"Wen","year":"2004","journal-title":"J Pract Diagn Ther"},{"key":"R35-20250131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PCC.0b013e3181936ab3","article-title":"Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting.","volume":"10","author":"Valoor","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"R36-20250131","first-page":"61","article-title":"[Observation on the efficacy of hydrocortisone in the treatment of septic shock in children].","volume":"10","author":"Yuan","year":"2010","journal-title":"Chin J Misdiagn"},{"key":"R37-20250131","doi-asserted-by":"crossref","first-page":"A446","DOI":"10.1136\/archdischild-2012-302724.1576","article-title":"1576 effect of dexamethasone therapy on the expression of macrophage migration inhibitory factor in critically ill children with septic shock.","volume":"97","author":"Mansour","year":"2012","journal-title":"Arch Dis Child"},{"key":"R39-20250131","doi-asserted-by":"crossref","first-page":"100335","DOI":"10.1016\/j.conctc.2019.100335","article-title":"Treatment preference and recruitment to pediatric RCTs: a systematic review.","volume":"14","author":"Beasant","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"key":"R40-20250131","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/cts.13220","article-title":"Facilitators and barriers to pediatric clinical trial recruitment and retention in rural and community settings: a scoping review of the literature.","volume":"15","author":"Watson","year":"2022","journal-title":"Clin Transl Sci"},{"key":"R41-20250131","doi-asserted-by":"crossref","first-page":"e031151","DOI":"10.1136\/bmjopen-2019-031151","article-title":"Partially randomised patient preference trials as an alternative design to randomised controlled trials: systematic review and meta-analyses.","volume":"9","author":"Wasmann","year":"2019","journal-title":"BMJ Open"},{"key":"R42-20250131","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/PCC.0000000000000642","article-title":"Strategies to maximize enrollment in a prospective study of comatose children in the PICU.","volume":"17","author":"McBain","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"R43-20250131","doi-asserted-by":"crossref","first-page":"104394","DOI":"10.1016\/j.ebiom.2022.104394","article-title":"Sepsis biomarkers and diagnostic tools with a focus on machine learning.","volume":"86","author":"Komorowski","year":"2022","journal-title":"EBioMedicine"},{"key":"R44-20250131","doi-asserted-by":"crossref","first-page":"e2023062967","DOI":"10.1542\/peds.2023-062967","article-title":"Pediatric sepsis diagnosis, management, and sub-phenotypes.","volume":"153","author":"Weiss","year":"2024","journal-title":"Pediatrics"},{"key":"R47-20250131","article-title":"Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS."},{"key":"R48-20250131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bjae.2018.01.005","article-title":"Steroid use in critical care.","volume":"18","author":"Young","year":"2018","journal-title":"BJA Educ"},{"key":"R49-20250131","doi-asserted-by":"crossref","first-page":"e073725","DOI":"10.1136\/bmj-2022-073725","article-title":"CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials.","volume":"381","author":"Junqueira","year":"2023","journal-title":"BMJ"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:01:54Z","timestamp":1738328514000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004551","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]}}}